WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck & Co., Inc. is pleased that the New Jersey Supreme Court reversed a lower court ruling that granted nationwide class-action status to insurance companies and HMOs seeking reimbursement for VIOXX expenditures. Merck had opposed class-action status in the case.
